Fallopian Tube Cancer
📧 Sign up to get email alerts when something new happens for Fallopian Tube Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-04-28Clinical Trial Update: Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies [Phase 2]
Phase 2 trial update for enzalutamide in AR-positive ovarian, fallopian tube, or primary peritoneal cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating cyclophosphamide with or without celecoxib in recurrent/persistent ovarian epithelial, fallopian tube, or primary p…
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer [Phase 2]
Phase 2 clinical trial update on the combination of cediranib and olaparib for recurrent cancers of the fallopian tube, ovary, or peritoneum…
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: MITO 35a: Olaparib Maintenance Therapy in Newly Diagnosed BRCA Wild-type Advanced Ovarian, Fallopian Tube and Primitive Peritoneal Cancer [Phase 2]
Phase 2 trial update of olaparib maintenance therapy in newly diagnosed BRCA wild-type advanced ovarian, fallopian tube, and primary periton…
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer [Phase 2]
Phase 2 trial update evaluating pembrolizumab in combination with chemotherapy as frontline treatment for advanced ovarian, primary peritone…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-03-17Clinical Trial Update: A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
This Phase 3 trial evaluated bevacizumab in addition to standard therapy for newly diagnosed Stage III/IV epithelial ovarian, fallopian tube…
-
CLINICAL_TRIALS trial_result · 2023-02-17Clinical Trial Update: A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
Phase 3 trial comparing atezolizumab plus paclitaxel, carboplatin, and bevacizumab versus control in newly diagnosed ovarian, fallopian tube…
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients [Phase 2]
A Phase 2 clinical trial update on heated intraperitoneal chemotherapy for ovarian cancer, with unclear status.
-
CLINICAL_TRIALS trial_result · 2023-01-30Clinical Trial Update: Trial of Pembrolizumab Following Weekly Paclitaxel for Platinum-resistant Ovarian, Fallopian Tube or Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating pembrolizumab after weekly paclitaxel in platinum-resistant ovarian, fallopian tube, or peritoneal cancer.
-
CLINICAL_TRIALS trial_result · 2023-01-05Clinical Trial Update: GL-ONC1 Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian Cancer [Phase 1, Phase 2]
Clinical trial update for GL-ONC1 oncolytic immunotherapy in recurrent or refractory ovarian cancer (Phase 1/Phase 2) completed.
-
CLINICAL_TRIALS trial_result · 2022-12-29Clinical Trial Update: Bevacizumab Plus Modiifed FOLFIRINOX in Ovarian, Fallopian Tube, or Primary Peritoneal Mucinous Carcinoma [Phase 2]
Phase 2 clinical trial evaluating bevacizumab with modified FOLFIRINOX for mucinous ovarian, fallopian tube, or primary peritoneal cancers.
-
CLINICAL_TRIALS trial_result · 2022-11-21Clinical Trial Update: A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer [Phase 3]
A single-arm Phase 3 trial of IMGN853 in Chinese adults with platinum-resistant epithelial ovarian cancer is ongoing, with conditions includ…
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 clinical trial evaluating gemcitabine hydrochloride alone or in combination with M6620 for recurrent ovarian, fallopian tube, or pri…
-
CLINICAL_TRIALS trial_result · 2022-10-05Clinical Trial Update: Olaparib, Durvalumab, and Tremelimumab in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube or Primary Peritoneal Cancer With BRCA1 or BRCA2 Mutation [Phase 2]
Phase 2 trial evaluating the combination of olaparib, durvalumab, and tremelimumab in patients with BRCA1/BRCA2-mutated recurrent or refract…
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab [NA]
Clinical trial assessing perfusion CT to predict outcomes in ovarian, fallopian tube, or peritoneal cancer treated with bevacizumab; the stu…
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating a vaccine therapy with paclitaxel and carboplatin in patients undergoing surgery for advanced ovarian cancer, prima…
-
CLINICAL_TRIALS trial_result · 2022-08-15Clinical Trial Update: A Study of Navicixizumab in Patients With Platinum Resistant Ovarian Cancer [Phase 3]
A Phase 3 clinical trial update for navicixizumab in platinum-resistant ovarian cancer is underway, with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: Pembrolizumab and Carboplatin in Treating Patients With Relapsed or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating pembrolizumab in combination with carboplatin for relapsed or refractory ovarian, fallopian tube, or p…
-
CLINICAL_TRIALS trial_result · 2022-06-24Clinical Trial Update: Paclitaxel and Ganetespib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
Clinical trial update for paclitaxel and ganetespib in recurrent ovarian, fallopian tube, or primary peritoneal cancer; study terminated wit…
-
CLINICAL_TRIALS trial_result · 2022-05-31Clinical Trial Update: Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1 [Phase 1, Phase 2]
Phase 1/2 trial evaluating NY-ESO-1–targeted T-cell therapy with or without decitabine in patients with NY-ESO-1–expressing advanced cancers…
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: A Study of Fluzoparib±Apatinib Versus Placebo Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on First-Line Platinum-Based Chemotherapy [Phase 3]
Phase 3 trial evaluating Fluzoparib with or without Apatinib versus placebo for maintenance in advanced ovarian cancer after response to fir…
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Advanced Epithelial Ovarian Carcinomas [Phase 2]
Phase 2 trial investigating autologous dendritic cells loaded with autologous tumor-associated antigens for advanced epithelial ovarian carc…
-
CLINICAL_TRIALS trial_result · 2022-02-11Clinical Trial Update: ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients [Phase 3]
Phase 3 ARIEL4 trial comparing rucaparib to chemotherapy in BRCA-mutant ovarian, fallopian tube, or primary peritoneal cancer has completed …
-
CLINICAL_TRIALS trial_result · 2022-02-07Clinical Trial Update: Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 1, Phase 2]
A clinical trial evaluating topotecan in combination with gefitinib (Iressa) for ovarian, peritoneal, or fallopian tube cancers has complete…
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery [Phase 2]
Phase 2 trial update on IGFBP-2 vaccine with combination chemotherapy for stage III-IV ovarian, fallopian tube, or primary peritoneal cancer…